CNS Pharmaceuticals, Inc. (CNSP)

CNS Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	6.97	0.55	10.06	5	14.04	7.24
Cash & Short-Term Investments	6.97	0.55	10.06	5	14.04	7.24
Cash Growth	666.66%	-94.54%	100.93%	-64.35%	93.88%	2461.15%
Prepaid Expenses	0.39	0.84	2.51	2.47	1.46	0.65
Other Current Assets	0.03	0.2	-	-	-	-
Total Current Assets	7.39	1.59	12.56	7.48	15.5	7.89
Property, Plant & Equipment	0	0	0.01	0.02	0.02	0.02
Long-Term Deferred Charges	-	-	-	0.33	0.33	-
Other Long-Term Assets	0.02	0.1	0.48	0.93	-	-
Total Assets	7.41	1.7	13.05	8.76	15.85	7.91
Accounts Payable	4.03	5.83	4.51	1.98	0.95	0.24
Accrued Expenses	-	-	-	0.22	0.52	0.02
Short-Term Debt	0.03	0.3	0.41	0.39	0.44	-
Other Current Liabilities	-	-	-	-	-	0.05
Total Current Liabilities	4.06	6.13	4.92	2.59	1.91	0.31
Total Liabilities	4.06	6.13	4.92	2.59	1.91	0.31
Common Stock	0.03	0.01	0	0	0.02	0.02
Additional Paid-In Capital	84.57	65.13	58.85	41.6	34.87	19.07
Retained Earnings	-81.25	-69.57	-50.72	-35.44	-20.95	-11.49
Shareholders' Equity	3.35	-4.43	8.13	6.16	13.95	7.6
Total Liabilities & Equity	7.41	1.7	13.05	8.76	15.85	7.91
Total Debt	0.03	0.3	0.41	0.39	0.44	-
Net Cash (Debt)	6.94	0.25	9.65	4.62	13.6	7.24
Net Cash Growth	700.09%	-97.43%	108.92%	-66.05%	87.81%	-
Working Capital	3.33	-4.54	7.64	4.88	13.59	7.58
Tangible Book Value	3.35	-4.43	8.13	6.16	13.95	7.6
Machinery	-	-	-	-	-	0.02

Updated Nov 14, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q